Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 58Squamous Cell Carcinoma of Head and Neck 55Head and Neck Neoplasms 55Prostatic Neoplasms 40Oropharyngeal Neoplasms 24Carcinoma, Non-Small-Cell Lung 23Carcinoma, Squamous Cell 21Rectal Neoplasms 19Breast Neoplasms 19Nasopharyngeal Neoplasms 14Neoplasm Metastasis 13Glioblastoma 13Carcinoma 13Esophageal Neoplasms 12Uterine Cervical Neoplasms 11Pancreatic Neoplasms 11Lung Neoplasms 11Glioma 11Esophageal Squamous Cell Carcinoma 11Sarcoma 9Radiation Injuries 8Neoplasms 8Laryngeal Neoplasms 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Tongue Neoplasms 7Mouth Neoplasms 7Hypopharyngeal Neoplasms 7Carcinoma, Hepatocellular 6Astrocytoma 6

Interventions

pembrolizumab 4Trastuzumab 4Oxaliplatin 4Fluorouracil 4Cyclophosphamide 4Carboplatin 4Radiotherapy 3Paclitaxel 3Endoscopy 3Docetaxel 3Cytarabine 3Chemoradiotherapy 3Capecitabine 3toripalimab 2Tretinoin 2Surgical Procedures, Operative 2Standard of Care 2Observation 2Neoadjuvant Therapy 2Metformin 2Magnetic Resonance Imaging 2Leucovorin 2Irinotecan 2Immunotherapy 2Immune Checkpoint Inhibitors 2Epirubicin 2Drug Therapy 2Doxorubicin 2Cisplatin 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pathologic Complete Response × Radiotherapy, Intensity-Modulated × Clear all
NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Sun Yat-sen University

Phase 2 Unknown
44 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡